capabilities
Real results.
Liquids
Oral formulations, including SEDDS
Parenteral formulations, including mAbs and mRNA
High-concentration biologics
Ophthalmic formulations, including emulsions
Solids
Wet and dry granulation
Amorphous solid dispersions
Immediate and extended-release tablets
Long-acting injectables
In situ-forming depots, including polymer and lipid systems
Drug suspensions
Microspheres and microparticles
Don’t see your challenge here?
We support a broad range of formulation challenges beyond those listed above.
AI algorithms and model learning can be used to continuously support seamless transition from early- to late-stage development
